Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
View Full Paper
Ask AI
Bookmark
Share
Abstract
Real-life data confirm nabiximols as an effective and well-tolerated treatment option for resistant MSS in clinical practice.
Discussion
No takes yet. Share an insight, caveat, or question.